Filing Details
- Accession Number:
- 0001144204-12-020117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-04 13:00:00
- Reporting Period:
- 2012-04-04
- Filing Date:
- 2012-04-04
- Accepted Time:
- 2012-04-04 15:45:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251213 | Ron Bentsur | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-04-04 | 71,400 | $1.38 | 460,376 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Of the 460,376 shares, 124,668 are shares of restricted stock.
Billionaire Hedge Funds
